Showing results (361-370 of 388) with videos related to
Sort By:
Pageof 39
Proceedings of the National Academy of Sciences of the United States of America|December 19, 1995
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer diseaseJ Poirier, M C Delisle, R Quirion, et al.Free Radical Biology & Medicine|September 18, 1999
Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotypeC Ramassamy, D Averill, U Beffert, et al.Neurobiology of Disease|December 14, 2001
Apolipoprotein C-I expression in the brain in Alzheimer's diseaseC Petit-Turcotte, S M Stohl, U Beffert, et al.Journal of Neuropathology and Experimental Neurology|September 15, 2001
Glioblastomas with an oligodendroglial component: a pathological and molecular studyJ He, K Mokhtari, M Sanson, et al.Molecular Pharmacology|November 9, 2018
Identification of Peracetylated Quercetin as a Selective 12-Lipoxygenase Pathway Inhibitor in Human PlateletsMarco S Doucet, Jean-Luc Jougleux, Samuel J Poirier, et al.Neurology|October 10, 2001
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progressionK Hoang-Xuan, J He, S Huguet, et al.Nature|May 29, 1997
Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor proteinJ Nalbantoglu, G Tirado-Santiago, A Lahsaïni, et al.Atherosclerosis|October 1, 1992
Effect of a novel series of macrocyclic hypolipidemic agents on plasma lipid and lipoprotein levels of four non-primate speciesJ C Gibson, H V Kothari, T M Genthe, et al.International Journal of Medicinal Chemistry|November 11, 2014
Clicked cinnamic/caffeic esters and amides as radical scavengers and 5-lipoxygenase inhibitorsJérémie A Doiron, Benoît Métayer, Ryan R Richard, et al.Ageing Research Reviews|March 12, 2009
Biological changes associated with healthy versus pathological aging: a symposium reviewM N Rajah, S Bastianetto, K Bromley-Brits, et al.Pageof 39